- Home
- ACM vs SNN Comparison
ACM vs SNN Comparison
Compare ACM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACM
- SNN
- Stock Information
- Founded
- ACM 1980
- SNN 1856
- Country
- ACM United States
- SNN United Kingdom
- Employees
- ACM N/A
- SNN N/A
- Industry
- ACM Military/Government/Technical
- SNN Industrial Specialties
- Sector
- ACM Consumer Discretionary
- SNN Health Care
- Exchange
- ACM Nasdaq
- SNN Nasdaq
- Market Cap
- ACM 14.7B
- SNN 13.2B
- IPO Year
- ACM 2007
- SNN 1999
- Fundamental
- Price
- ACM $115.08
- SNN $30.28
- Analyst Decision
- ACM Strong Buy
- SNN Hold
- Analyst Count
- ACM 8
- SNN 3
- Target Price
- ACM $119.88
- SNN $27.50
- AVG Volume (30 Days)
- ACM 969.4K
- SNN 1.2M
- Earning Date
- ACM 08-04-2025
- SNN 07-31-2025
- Dividend Yield
- ACM 0.91%
- SNN 2.37%
- EPS Growth
- ACM N/A
- SNN 56.15
- EPS
- ACM 4.58
- SNN 0.47
- Revenue
- ACM $16,047,510,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- ACM $3.29
- SNN $6.87
- Revenue Next Year
- ACM $5.98
- SNN $5.19
- P/E Ratio
- ACM $25.07
- SNN $33.29
- Revenue Growth
- ACM 4.55
- SNN 4.70
- 52 Week Low
- ACM $84.33
- SNN $23.69
- 52 Week High
- ACM $118.56
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- ACM 60.93
- SNN 54.96
- Support Level
- ACM $114.09
- SNN $29.50
- Resistance Level
- ACM $116.66
- SNN $31.43
- Average True Range (ATR)
- ACM 1.58
- SNN 0.42
- MACD
- ACM -0.04
- SNN 0.02
- Stochastic Oscillator
- ACM 70.38
- SNN 56.27
About ACM AECOM
Aecom is one of the largest global providers of design, engineering, construction, and management services. It serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $16.1 billion in sales in fiscal 2024.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.